Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies

Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies

US Patent 11466099 · Granted Oct 11, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions targeting prostate-specific membrane antigen and methods for making2025
Antibody library and method2025
Anti-S100A4 humanized antibodies, uses and methods2025
HER-2 targeted bispecific compositions and methods for making and using the same2025
Biomarkers and methods of use for radiation-induced lung injury2023
Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies2021
Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies2021
Method of treating one or more symptoms of pulmonary fibrosis by administering i2021
Method to reduce pulmonary arterial hypertension by administering inhibitors of 2021
Biomarkers for assessing idiopathic pulmonary fibrosis2021
Methods for characterizing cancer2020
Compositions and methods for treating and preventing lung injury2019